Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections.
Keywords:
streptococcus pneumoniae, penicillin resistance, rifampin, chloranphenicol
Abstract
Streptococcus pneumoniae, a common pathogen in pediatric infections, has become resistant to penicillin and make these infections difficult to treat. Rifampin and chloramphenicol have been recommended as alternative therapies, since they are less costly and more accessible to communities with limited resources. However, their use may be restricted by the differing levels of resistance found in target populations. The objective was to determine minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) for chloramphenicol and rifampin in strains of S. pneumoniae. These strains were newly isolated from children under age 5 that had demonstrated systemic infections and meningitis. A subgroup of 107 isolates of S. pneumoniae was selected from 324 strains isolated during a period of 2 years (1994-1996). Among these isolates, 60 were penicillin-resistant and 47 were susceptible; 53 isolates were from children with meningitis. MIC and MBC for chloramphenicol and rifampicin were obtained by standard methods recommended by the National Committee for Clinical Laboratory Standards (NCCLS). S. pneumoniae ATCC strain 49619 served as the control. An isolate was considered susceptible to chloramphenicol when MIC = 4 microg/ml and resistant when MIC = 8 microg/ml. A strain was considered susceptible to rifampin when MIC = 1 microg/ml and resistant when MIC = 4 microg/ml. MBC was determined by recording the lower concentration of the antibiotic that inhibited 99.9% of the initial inoculum. Chloramphenicol resistance was found in 21% of the 107 isolates. In the group susceptible to penicillin, 11% were resistant to chloramphenicol and in the group resistant to penicillin 28% was resistant to chloramphenicol as well. MBC was found > 4 microg/ml in 28% of the isolates susceptible to penicillin and in 60% of the resistant isolates. No isolates were found resistant to rifampin. However, 2 penicillin resistant isolates showed CBM > 1 microg/ml to rifampin, and one with CIM = 1 microg/ml had a MBC to rifampicin of 16 microg/ml. Meningitis isolates showed higher CIM and CBM than the group of total isolates. These data suggest that chloramphenicol is not recommended for invasive infections caused by S. pneumoniae in Colombia. Rifampin is a more effective therapy in combination with other antibiotics for treatment of this kind of infections. Further studies are necessary to clarify the significance of low levels of MBC to rifampin found in some strains, since this may affect the efficacy of therapies that include this antibiotic.Downloads
Download data is not yet available.
How to Cite
1.
Hernández M, Mejía GI, Trujillo H, Robledo J. Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections. biomedica [Internet]. 2003 Dec. 1 [cited 2024 May 19];23(4):456-61. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/1239
Some similar items:
- César A. Arias, Marylin Hidalgo, Jinnethe Reyes, Ana María Cárdenas, Lorena Díaz, Sandra Ríncon, Natasha Vanegas, Paula Lucía Díaz, Elizabeth Castañeda, Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci , Biomedica: Vol. 28 No. 2 (2008)
- Eliana Parra, Elizabeth Castañeda, Jaime Moreno, Identification of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis by polymerase chain reaction , Biomedica: Vol. 27 No. 3 (2007)
- Marylin Hidalgo, Claudia Santos, Carolina Duarte, Elizabeth Castañeda, Clara Inés Agudelo, Increase in erythromycin-resistant Streptococcus pneumoniae in Colombia, 1994-2008 , Biomedica: Vol. 31 No. 1 (2011)
- Lucía Carolina Leal-Esteban, Jessica Lineth Rojas, Andrea Lizeth Jaimes, Juan David Montoya, Nilton Edu Montoya, Lily Leiva, Claudia Milena Trujillo-Vargas, An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae , Biomedica: Vol. 32 No. 1 (2012)
- Daniel Echeverri, María de los Ángeles Vargas, Lorena Matta, Fernando Rosso, Janier Daniel Segura, Invasive Streptococcus pneumoniae infection (Austrian syndrome): a case report , Biomedica: Vol. 35 No. 1 (2015)
- lngrid J. Peñuela, Aura Lucía Leal, Elizabeth Castañeda, Nasopharingeal carriage and antimicrobial resistance to Streptococcus pneumoniae in children of a day care center in Santa Fe de Bogotá , Biomedica: Vol. 19 No. 3 (1999)
- Jaime Moreno, Elizabeth Castañeda, Molecular characterization of invasive isolations of penicillin-resistant Streptococcus pneumoniae recovered from adult patients. , Biomedica: Vol. 23 No. 1 (2003)
- Jaime Moreno, Vienvilay Phandanouvong, Elizabeth Castañeda, Molecular surveillance of invasive penicillin-resistant Streptococcus pneumoniae Colombian isolates recovered from children less than 5 years of age. , Biomedica: Vol. 24 No. 3 (2004)
- Clara Inés Agudelo, Jaime Moreno, Olga Marina Sanabria, María Victoria Ovalle, José Luis Di Fabio, Elizabeth Castañeda, Streptococcus pneumoniae: serotype evolution and patterns of antimicrobial susceptibility in invasive isolates from 11 years surveillance (1994 -2004) in Colombia. , Biomedica: Vol. 26 No. 2 (2006)
- Carolina Firacative, Jaime Moreno, Elizabeth Castañeda, Molecular characterization of Colombian invasive serotype 5 Streptococcus pneumoniae isolates recovered between 1994 and 2004. , Biomedica: Vol. 26 No. 2 (2006)
Published
2003-12-01
Issue
Section
Original articles
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |